PHC (PARIS HEPATOLOGY CONFERENCE) 2018 – Pre-Programme

SCIENTIFIC PRELIMINARY PROGRAMME

Download the pre-programme

HEPATITIS C Conference - Monday, January 15th 2018

  • 08:30 - 08:45 Introduction: Liver Diseases in 2018: a huge and neglected Public Health burden - Patrick MARCELLIN (France)
  • 08:45 - 09:00 Treatment of HCV: 100 % cure ? - Tarik ASSELAH (France)
  • 09:00 - 09:15 Difficult to treat patients - Stefan ZEUZEM (Germany)
  • 09:30 - 09:50 Round table discussion
  • 09:50 - 10:10 CLINICAL CASE
  • Management of a patient with HCV related vasculitis - Eugene SCHIFF (USA)
  • 10:10 - 10:40 Coffee Break
  • 10:40 - 10:55 Cost benefit of treatment in F1 patients - Graham FOSTER (UK)
  • 11:10 - 11:25 The next wave of HCV : The epidemic of intravenous drug use - Mitchell SHIFFMAN (USA)
  • 11:25 - 11:45 Round table discussion
  • 11:45 - 12:30 State of the art LECTURE and award - Chairman: Patrick MARCELLIN (France)
  • Is global elimination of HCV realistic ? - Antonio CRAXI (Italy)
  • 12:30 - 14:30 Lunch workshops
  • 15:00 - 15:15 Management of a patient with NASH in real life - Lawrence SERFATY (France)
  • 15:15 - 15:30 Future therapies in NASH - Arun SANYAL (USA)
  • 15:30 - 15:45 Round table discussion
  • 16:15 - 16:35 Coffee break
  • 18:30 Ajournement

HEPATITIS B Conference - Tuesday, January 16th 2018

  • 09:30 - 09:50 Round table discussion
  • 10:20 - 10:40 Coffee Break
  • 10:55 - 11:10 Vaccination: where we are? - Paolo BONANNI (Italy)
  • 11:10 - 11:25 How to improve access to therapy for HBV patients? - Fabien ZOULIM (France)
  • 11:25 - 11:40 Round table discussion
  • 11:40 - 12:10 How to control HBV in high endemic regions? - Chairman: Patrick MARCELLIN (France)
  • Sub-saharian African - TBC
  • 12:30 - 14:30 Lunch Workshops
  • 14:30 - 14:45 Infections complicating cirrhosis - Paolo ANGELI (Italy)
  • 14:45 - 15:00 Allocation of liver grafts throughout the world. What is the best system? - Pierre-Alain CLAVIEN (Switzerland)
  • 15:00 - 15:15 How to improve the long-term outcome after liver transplantation - François DURAND (France)
  • 15:15 - 15:30 Round table discussion
  • 15:30 - 15:50 STATE OF THE ART LECTURE - Immunotherapy in liver diseases - Dominique VALLA (France)
  • 15:50 - 16:05 Updated 2018 EASL CPGs - Peter GALLE (Belgium)
  • 16:05 - 16:20 The impact of DAAs on HCC occurence - Didier SAMUEL (France)
  • 16:20 - 16:35 New approaches in therapy - Bruno SANGRO (Spain)
  • 16:35 - 16:50 Round table discussion
  • 17:30 Ajournement